288 related articles for article (PubMed ID: 22297670)
1. MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice.
Mulay SR; Thomasova D; Ryu M; Anders HJ
Kidney Int; 2012 Jun; 81(12):1199-211. PubMed ID: 22297670
[TBL] [Abstract][Full Text] [Related]
2. Double-edged sword: a p53 regulator mediates both harmful and beneficial effects in experimental acute kidney injury.
McNicholas BA; Griffin MD
Kidney Int; 2012 Jun; 81(12):1161-4. PubMed ID: 22648356
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 signalling promotes ex vivo tubular epithelial cell survival and regeneration via murine double minute (MDM)-2.
Hagemann JH; Thomasova D; Mulay SR; Anders HJ
Nephrol Dial Transplant; 2013 Aug; 28(8):2028-37. PubMed ID: 23476038
[TBL] [Abstract][Full Text] [Related]
4. MDM2 beyond cancer: podoptosis, development, inflammation, and tissue regeneration.
Ebrahim M; Mulay SR; Anders HJ; Thomasova D
Histol Histopathol; 2015 Nov; 30(11):1271-82. PubMed ID: 26062755
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MDM2 attenuates neointimal hyperplasia via suppression of vascular proliferation and inflammation.
Hashimoto T; Ichiki T; Ikeda J; Narabayashi E; Matsuura H; Miyazaki R; Inanaga K; Takeda K; Sunagawa K
Cardiovasc Res; 2011 Sep; 91(4):711-9. PubMed ID: 21498419
[TBL] [Abstract][Full Text] [Related]
6. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma.
Drakos E; Thomaides A; Medeiros LJ; Li J; Leventaki V; Konopleva M; Andreeff M; Rassidakis GZ
Clin Cancer Res; 2007 Jun; 13(11):3380-7. PubMed ID: 17545546
[TBL] [Abstract][Full Text] [Related]
8. Murine Double Minute-2 Inhibition Ameliorates Established Crescentic Glomerulonephritis.
Mulay SR; Romoli S; Desai J; Honarpisheh MM; Kumar SV; Anders HJ; Thomasova D
Am J Pathol; 2016 Jun; 186(6):1442-53. PubMed ID: 27102769
[TBL] [Abstract][Full Text] [Related]
9. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein promotes acute kidney injury by impairing G1/S-dependent tubular epithelium cell regeneration.
Tang Y; Huang XR; Lv J; Chung AC; Zhang Y; Chen JZ; Szalai AJ; Xu A; Lan HY
Clin Sci (Lond); 2014 May; 126(9):645-59. PubMed ID: 24206243
[TBL] [Abstract][Full Text] [Related]
11. Phlda3, a urine-detectable protein, causes p53 accumulation in renal tubular cells injured by cisplatin.
Lee CG; Kang YJ; Kim HS; Moon A; Kim SG
Cell Biol Toxicol; 2015 Apr; 31(2):121-30. PubMed ID: 25809501
[TBL] [Abstract][Full Text] [Related]
12. Subcellular trafficking of tubular MDM2 implicates in acute kidney injury to chronic kidney disease transition during multiple low-dose cisplatin exposure.
Su H; Ye C; Lei CT; Tang H; Zeng JY; Yi F; Zhang C
FASEB J; 2020 Jan; 34(1):1620-1636. PubMed ID: 31914692
[TBL] [Abstract][Full Text] [Related]
13. Podocyte loss involves MDM2-driven mitotic catastrophe.
Mulay SR; Thomasova D; Ryu M; Kulkarni OP; Migliorini A; Bruns H; Gröbmayr R; Lazzeri E; Lasagni L; Liapis H; Romagnani P; Anders HJ
J Pathol; 2013 Jul; 230(3):322-35. PubMed ID: 23749457
[TBL] [Abstract][Full Text] [Related]
14. Signaling Rho-kinase mediates inflammation and apoptosis in T cells and renal tubules in cisplatin nephrotoxicity.
Nozaki Y; Kinoshita K; Hino S; Yano T; Niki K; Hirooka Y; Kishimoto K; Funauchi M; Matsumura I
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F899-909. PubMed ID: 25651561
[TBL] [Abstract][Full Text] [Related]
15. MDM2 inhibitor Nutlin-3a suppresses proliferation and promotes apoptosis in osteosarcoma cells.
Wang B; Fang L; Zhao H; Xiang T; Wang D
Acta Biochim Biophys Sin (Shanghai); 2012 Aug; 44(8):685-91. PubMed ID: 22843172
[TBL] [Abstract][Full Text] [Related]
16. p53-independent roles of MDM2 in NF-κB signaling: implications for cancer therapy, wound healing, and autoimmune diseases.
Thomasova D; Mulay SR; Bruns H; Anders HJ
Neoplasia; 2012 Dec; 14(12):1097-101. PubMed ID: 23308042
[TBL] [Abstract][Full Text] [Related]
17. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.
Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM
Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697
[TBL] [Abstract][Full Text] [Related]
18. 6-Shogaol protects against ischemic acute kidney injury by modulating NF-κB and heme oxygenase-1 pathways.
Han SJ; Kim M; D'Agati VD; Lee HT
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F743-F756. PubMed ID: 31313953
[TBL] [Abstract][Full Text] [Related]
19. Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin.
Efeyan A; Ortega-Molina A; Velasco-Miguel S; Herranz D; Vassilev LT; Serrano M
Cancer Res; 2007 Aug; 67(15):7350-7. PubMed ID: 17671205
[TBL] [Abstract][Full Text] [Related]
20. Knockout of the interleukin-36 receptor protects against renal ischemia-reperfusion injury by reduction of proinflammatory cytokines.
Nishikawa H; Taniguchi Y; Matsumoto T; Arima N; Masaki M; Shimamura Y; Inoue K; Horino T; Fujimoto S; Ohko K; Komatsu T; Udaka K; Sano S; Terada Y
Kidney Int; 2018 Mar; 93(3):599-614. PubMed ID: 29241623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
